These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 5964864)
1. Comparative evaluation of blood levels and tolerance of sodium PAS and conjugated PAS and ascorbic acid. Schless JM; Inglis RM; Hammond JH; Hale JM Dis Chest; 1966 Dec; 50(6):595-600. PubMed ID: 5964864 [No Abstract] [Full Text] [Related]
2. Studies of conjugated PAS and ascorbic acid and other forms of para-aminosalicylic acid. I. Patient tolerance. DONNERBERG RL; BROWNING RH; ATWELL RJ Am Rev Tuberc; 1957 Nov; 76(5):877-9. PubMed ID: 13478843 [No Abstract] [Full Text] [Related]
3. [Concentration and tolerance of INH and PAS in single daily doses. (Preliminary report)]. Vil'derman AM; Finn ER; Busygina RN; Draganiuk KA; Ezerskiĭ VF; Evgrafova ZA Probl Tuberk; 1965; 43(11):30-4. PubMed ID: 5875728 [No Abstract] [Full Text] [Related]
4. [Blood concentration of PAS with different doses and methods of administration]. Korotaev GA; Kozulitsyna TI; Vasil'eva ZS Ter Arkh; 1971 Jan; 43(1):37-40. PubMed ID: 5574533 [No Abstract] [Full Text] [Related]
5. [COMPARATIVE STUDIES ON THE TOLERANCE AND ABSORPTION OF SODIUM AND POTASSIUM SALTS OF PAS]. NIKODEMOWICZ E; OSTROWSKA A Gruzlica (1926); 1964 May; 32():459-64. PubMed ID: 14180617 [No Abstract] [Full Text] [Related]
6. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol. Lehmann J Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904 [No Abstract] [Full Text] [Related]
7. [Distribution of dichlortetracycline, pasomycin and phenoxymethyl penicillin in the organism of the patients with burns following administration of a combined preparation]. Ved'mina EA; Vasina TA; Morozov SS; Ermol'eva ZV Antibiotiki; 1968 Feb; 13(2):143-7. PubMed ID: 4174483 [No Abstract] [Full Text] [Related]
8. [Studies on the metabolism of para-aminosalicylic acid in the body. IV. Effect of sodium salt of para-animosalicylic acid administered orally in coated tablets soluble in the intestine on the bacteriostatic level and on drug tolerance]. Hornung S; Nilodemowicz E; Owsiński J; Rapf T Gruzlica; 1967 Jul; 35(7):657-64. PubMed ID: 4865322 [No Abstract] [Full Text] [Related]
9. [The level of p-aminosalicyclic acid in the blood in oral treatment with a calcium-aluminum-p-aminosalicylate]. Mulder RJ; Huizinga T Ned Tijdschr Geneeskd; 1968 Sep; 112(37):1630-4. PubMed ID: 4878452 [No Abstract] [Full Text] [Related]
10. Studies of conjugated PAS and ascorbic acid and other forms of para-aminosalicylic acid. II. Comparison of twenty-four-hour blood serum concentrations. FISCHER HK; BROWNING RH; DONNERBERG RL; PRATT PC; ATWELL RJ Am Rev Tuberc; 1957 Nov; 76(5):880-7. PubMed ID: 13478844 [No Abstract] [Full Text] [Related]
11. Toleration and absorption of sodium para-aminosalicylate and para-aminosalicylic acid (neopasalate). Comparison with other forms of para-aminosalicylic acid. Yue WY; Cohen SS Dis Chest; 1966 Feb; 49(2):165-74. PubMed ID: 5907972 [No Abstract] [Full Text] [Related]
12. Bioavailability of aminosalicylic acid and its various salts in humans IV: comparison of four brands of the sodium salt. Pentikäinen PJ; Wan SH; Azarnoff DL J Pharm Sci; 1974 Sep; 63(9):1431-4. PubMed ID: 4610119 [No Abstract] [Full Text] [Related]
13. [Early results of intermittent and continuous modified treatment with standard drugs and limited dosage of PAS in previously untreated pulmonary tuberculosis. Preliminary report]. Stopczyk J; Niemirowska H; Pecyna-Sielewicz J; Janowiec M Gruzlica; 1970; 38(7):705-18. PubMed ID: 5453680 [No Abstract] [Full Text] [Related]
14. [CONCENTRATION OF NA-PAS IN THE BLOOD AND ITS TOLERANCE FOLLOWING SINGLE ORAL ADMINISTRATION OF THE WHOLE DAILY DOSE]. WARESKA W; IZDEBSKA-MAKOSA Z Gruzlica (1926); 1964 Apr; 32():305-9. PubMed ID: 14183277 [No Abstract] [Full Text] [Related]
15. [Penetration and dynamics of concentration of dichlortetracycline, pasomycin and phenoxymethylpenicillin in lymphoid tissue and blood of patients during administration in complex preparation]. Ved'mina EA; Vasina TA; Gamaleia LA; Skurkovich GV; Ioffe IaS Antibiotiki; 1969 Dec; 14(12):1123-7. PubMed ID: 4190063 [No Abstract] [Full Text] [Related]
16. Steatorrhea induced by para-aminosalicylic acid. Levine RA Ann Intern Med; 1968 Jun; 68(6):1265-70. PubMed ID: 4871323 [No Abstract] [Full Text] [Related]
17. [Treatment of tuberculosis of the female sex organs]. Kolachevskaia EN Akush Ginekol (Mosk); 1974 Oct; (10):53-7. PubMed ID: 4440833 [No Abstract] [Full Text] [Related]
18. 5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema. Gionchetti P; Belluzzi A; Campieri M; Torresan F; Tabanelli GM; Brignola C; Miglioli M; Barbara L Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):667-9. PubMed ID: 3236941 [TBL] [Abstract][Full Text] [Related]
19. Importance of the type of dosage form and saturable acetylation in determining the bioactivity of p-aminosalicylic acid. Wagner JG; Holmes PD; Wilkinson PK; Blair DC; Stoll RG Am Rev Respir Dis; 1973 Sep; 108(3):536-46. PubMed ID: 4745249 [No Abstract] [Full Text] [Related]
20. Bioavailability studies on p-aminosalicylic acid and its various salts in man. II. Comparison of parasal and pascorbic. Pentikainen P; Wan SH; Azarnoff DL Am Rev Respir Dis; 1973 Dec; 108(6):1340-70. PubMed ID: 4751720 [No Abstract] [Full Text] [Related] [Next] [New Search]